RAVULIZUMAB for Atypical haemolytic uraemic syndrome: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 14 adverse event reports in the FDA FAERS database where RAVULIZUMAB was used for Atypical haemolytic uraemic syndrome.
Most Reported Side Effects for RAVULIZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 11 | 9.3% | 1 | 5 |
| Pneumonia | 8 | 6.8% | 1 | 7 |
| Drug ineffective | 5 | 4.2% | 0 | 2 |
| Neuromyelitis optica spectrum disorder | 5 | 4.2% | 0 | 4 |
Other Indications for RAVULIZUMAB
Paroxysmal nocturnal haemoglobinuria (50)
Myasthenia gravis (25)
Neuromyelitis optica spectrum disorder (11)
Other Drugs Used for Atypical haemolytic uraemic syndrome
ECULIZUMAB (5,848)
RAVULIZUMAB-CWVZ (1,121)
RITUXIMAB (16)
METHYLPREDNISOLONE (12)
PREDNISONE (12)
MYCOPHENOLATE MOFETIL (7)
ERYTHROPOIETIN (5)